Investigators at the National Institute of Neurological Disorders and Stroke (NINDS) are seeking patients with mild to moderate dementia for a clinical trial of an experimental compound. This trial will be conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
Eligible patients must be between the ages of 40 and 90, otherwise healthy, and ambulatory, and they must be off all antidementia medications for 1 month. All treatment-related expenses will be paid by the NIH.
To refer eligible patients, physicians should send a letter of referral and case summary to Dr. Thomas Chase, Chief, Experimental Therapeutics Branch, NINDS, NIH, Building 10, Room 5C106, 10 Center Dr. MSC 1406, Bethesda, MD 20892-1406; fax: (301) 496-6609. Please call Kimberly Mosby with any questions at (301) 496-4604 or 1-800-362-3479.